Does LANSOPRAZOLE Cause Second primary malignancy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Second primary malignancy have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.0% of all adverse event reports for LANSOPRAZOLE.
7
Reports of Second primary malignancy with LANSOPRAZOLE
0.0%
of all LANSOPRAZOLE reports
2
Deaths
5
Hospitalizations
How Dangerous Is Second primary malignancy From LANSOPRAZOLE?
Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LANSOPRAZOLE Cause?
Chronic kidney disease (32,517)
Acute kidney injury (16,359)
Renal failure (12,509)
End stage renal disease (9,734)
Renal injury (9,383)
Tubulointerstitial nephritis (3,860)
Death (2,517)
Gastrooesophageal reflux disease (2,482)
Off label use (2,183)
Nephrogenic anaemia (2,162)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which LANSOPRAZOLE Alternatives Have Lower Second primary malignancy Risk?
LANSOPRAZOLE vs LANTHANUM
LANSOPRAZOLE vs LANTUS
LANSOPRAZOLE vs LANTUS SOLOSTAR
LANSOPRAZOLE vs LAPATINIB
LANSOPRAZOLE vs LAPATINIB DITOSYLATE